Assignee
GENESIS RES & DEV CORP LTD
US·32 granted patents·16 pending applications·642 citations·filing 1996–2007
Top patents by PatentIndex Score
48 records- 0194US6380362B1Polynucleotides, polypeptides expressed by the polynucleotides and methods for their useGENESIS RES & DEV CORP LTD·Filed 2000·Granted Apr 30, 2002·99 cites·3 claims
- 0292US6410718B1Materials and methods for the modification of plant lignin contentGENESIS RES & DEV CORP LTD·Filed 2000·Granted Jun 25, 2002·36 cites·6 claims
- 0391US6544772B1Polynucleotides, materials incorporating them, and methods for using themGENESIS RES & DEV CORP LTD·Filed 2000·Granted Apr 8, 2003·45 cites·9 claims
- 0491US6476209B1Polynucleotides, materials incorporating them, and methods for using themGENESIS RES & DEV CORP LTD·Filed 2000·Granted Nov 5, 2002·66 cites·11 claims
- 0590US6596925B1Compositions and methods for the modification of gene expressionGENESIS RES & DEV CORP LTD·Filed 2000·Granted Jul 22, 2003·37 cites·14 claims
- 0686US6255559B1Methods for producing genetically modified plants, genetically modified plants, plant materials and plant products produced therebyGENESIS RES & DEV CORP LTD·Filed 1998·Granted Jul 3, 2001·18 cites·16 claims
- 0780US6150502APolypeptides expressed in skin cellsGENESIS RES & DEV CORP LTD·Filed 1998·Granted Nov 21, 2000·58 cites·22 claims
- 0879US5952486AMaterials and methods for the modification of plant lignin contentGENESIS RES & DEV CORP LTD·Filed 1997·Granted Sep 14, 1999·41 cites·23 claims
- 0977US6001361AMycobacterium vaccae antigensGENESIS RES & DEV CORP LTD·Filed 1997·Granted Dec 14, 1999·43 cites·6 claims
- 1076US7083791B2Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptidesGENESIS RES & DEV CORP LTD·Filed 2003·Granted Aug 1, 2006·13 cites·5 claims
- 1173US5985287ACompounds and methods for treatment and diagnosis of mycobacterial infectionsGENESIS RES & DEV CORP LTD·Filed 1997·Granted Nov 16, 1999·43 cites·5 claims
- 1271US6380459B1Compositions and methods for the modification of gene expressionGENESIS RES & DEV CORP LTD·Filed 1999·Granted Apr 30, 2002·30 cites·17 claims
- 1369US6204434B1Materials and methods for the modification of plant lignin contentGENESIS RES & DEV CORP LTD·Filed 1998·Granted Mar 20, 2001·25 cites·33 claims
- 1468US6768041B2Compositions isolated from plant cells and their use in the modification of plant cell signalingGENESIS RES & DEV CORP LTD·Filed 2002·Granted Jul 27, 2004·4 cites·18 claims
- 1563US6716430B2Compositions isolated from M. vaccae and their use in the modulation of immune responsesGENESIS RES & DEV CORP LTD·Filed 2002·Granted Apr 6, 2004·1 cites·11 claims
- 1662US6242419B1Compositions isolated from stromal cells and methods for their useGENESIS RES & DEV CORP LTD·Filed 1999·Granted Jun 5, 2001·17 cites·7 claims
- 1761US2007004666A1Methods for modulating apoptotic cell deathGENESIS RES & DEV CORP LTD·Filed 2006·Application pending·0 cites
- 1858US7192590B2Compounds for treatment of infectious and immune system disorders and methods for their useGENESIS RES & DEV CORP LTD·Filed 2003·Granted Mar 20, 2007·0 cites·4 claims
- 1958US6573095B1Polynucleotides isolated from skin cellsGENESIS RES & DEV CORP LTD·Filed 1999·Granted Jun 3, 2003·17 cites·25 claims
- 2056US6451604B1Compositions affecting programmed cell death and their use in the modification of forestry plant developmentGENESIS RES & DEV CORP LTD·Filed 1999·Granted Sep 17, 2002·12 cites·19 claims
- 2155US2008145313A1Compositions and Methods for the Treatment and Prevention of Neoplastic DisordersGENESIS RES & DEV CORP LTD·Filed 2007·Application pending·0 cites
- 2253US6653528B1Pinus radiata nucleic acids encoding O-methyl transferase and methods for the modification of plant lignin content therewithGENESIS RES & DEV CORP LTD·Filed 1998·Granted Nov 25, 2003·8 cites·27 claims
- 2350US2003082724A1Compositions affecting programmed cell death and their use in the modification of plant developmentGENESIS RES & DEV CORP LTD·Filed 2002·Application pending·0 cites
- 2450US2004247622A1Methods and compounds for the treatment of immunologically-mediated diseases using Mycobacterium vaccaeGENESIS RES & DEV CORP LTD·Filed 2004·Application pending·0 cites
- 2549US2003229922A1Materials and methods for the modification of plant cell wall polysaccharidesGENESIS RES & DEV CORP LTD·Filed 2003·Application pending·0 cites
- 2647US5912168ACD95 regulatory gene sequencesGENESIS RES & DEV CORP LTD·Filed 1996·Granted Jun 15, 1999·8 cites·10 claims
- 2746US7041295B2Compounds for treatment of infectious and immune system disorders and methods for their useGENESIS RES & DEV CORP LTD·Filed 2002·Granted May 9, 2006·0 cites·5 claims
- 2846US6797271B2Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptidesGENESIS RES & DEV CORP LTD·Filed 2001·Granted Sep 28, 2004·0 cites·15 claims
- 2946US2003022835A1Compositions isolated from skin cells and methods for their useGENESIS RES & DEV CORP LTD·Filed 2002·Application pending·0 cites
- 3044US6328978B1Methods for the treatment of immunologically-mediated skin disordersGENESIS RES & DEV CORP LTD·Filed 1999·Granted Dec 11, 2001·5 cites·9 claims
- 3144US2003138905A1Compositions isolated from bovine mammary gland and methods for their useGENESIS RES & DEV CORP LTD·Filed 2002·Application pending·0 cites
- 3242US6410720B1Compounds and methods for treatment and diagnosis of mycobacterial infectionsGENESIS RES & DEV CORP LTD·Filed 1998·Granted Jun 25, 2002·3 cites·18 claims
- 3341US2003091981A1Funtional assay for genes involved in xylogenesisGENESIS RES & DEV CORP LTD·Filed 2002·Application pending·0 cites
- 3441US2005112642A1Fibroblast growth factor receptors and methods for their useGENESIS RES & DEV CORP LTD·Filed 2004·Application pending·0 cites
- 3541US2005009750A1Fibroblast growth factor receptors and methods for their useGENESIS RES & DEV CORP LTD·Filed 2004·Application pending·0 cites
- 3640US2002169302A1Compositions isolated from bovine mammary gland and methods for their useGENESIS RES & DEV CORP LTD·Filed 2002·Application pending·0 cites
- 3739US6406704B1Compounds and methods for treatment and diagnosis of mycobacterial infectionsGENESIS RES & DEV CORP LTD·Filed 1998·Granted Jun 18, 2002·5 cites·21 claims
- 3838US6436898B1Compounds for treatment of infectious and immune system disorders and methods for their useGENESIS RES & DEV CORP LTD·Filed 1999·Granted Aug 20, 2002·2 cites·27 claims
- 3938US6361776B1Compounds isolated from M. vaccae and their use in modulation of immune responsesGENESIS RES & DEV CORP LTD·Filed 1999·Granted Mar 26, 2002·2 cites·12 claims
- 4036US2003143676A1Fibroblast growth factor receptors and methods for their useGENESIS RES & DEV CORP LTD·Filed 2002·Application pending·0 cites
- 4136US2003147861A1Compounds and methods for the modulation of immune responsesGENESIS RES & DEV CORP LTD·Filed 2002·Application pending·0 cites
- 4235US6350457B1Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccaeGENESIS RES & DEV CORP LTD·Filed 1999·Granted Feb 26, 2002·1 cites·19 claims
- 4334US2005202077A1Targeted delivery of RNA interference moleculesGENESIS RES & DEV CORP LTD·Filed 2005·Application pending·0 cites
- 4433US2006115483A1Fibroblast growth factor receptors and methods for their useGENESIS RES & DEV CORP LTD·Filed 2005·Application pending·0 cites
- 4533US2007110752A1Fibroblast growth factor receptors and methods for their useGENESIS RES & DEV CORP LTD·Filed 2006·Application pending·0 cites
- 4632US6359198B1Compositions isolated from plant cells and their use in the modificationGENESIS RES & DEV CORP LTD·Filed 1999·Granted Mar 19, 2002·2 cites·18 claims
- 4732US6358734B1Compounds for treatment of infectious and immune system disorders and methods for their useGENESIS RES & DEV CORP LTD·Filed 1999·Granted Mar 19, 2002·0 cites·9 claims
- 4827US6284255B1Compounds and methods for treatment and diagnosis of mycobacterial infectionsGENESIS RES & DEV CORP LTD·Filed 1996·Granted Sep 4, 2001·1 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when GENESIS RES & DEV CORP LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →